Published Date: 27 Apr 2023
Residential and Outpatient Schizophrenia Patients' Sleep Health Varies.
Read Full NewsMRI offers the possibility of personalized neoadjuvant chemotherapy for patients with HER2-positive breast cancer, but it may not be ready for prime time.
Patients with non-squamous non-small cell cancer may achieve similar outcomes with a subcutaneous formulation of the immunotherapy toripalimab as with IV administration.
Conditional approval of intravesical gene therapy was supported by clinical evidence showing a 53.4% complete response rate in patients with treatment-resistant non-muscle-invasive bladder cancer.
A phase 2 study evaluates the safety and efficacy of brexucabtagene autoleucel in BTKi-naïve patients with relapsed/refractory mantle cell lymphoma.
1.
The American College of Physicians updated its recommendations for colorectal cancer screening.
2.
Acupuncture may alleviate nocturia in men treated for prostate cancer
3.
Report reveals lung cancer is the leading cause of cancer deaths in Florida
4.
Life quality after childhood cancer is quantifiable thanks to outcome indicators.
5.
Tumor characteristics found to differ for melanomas in children, teens and young adults
1.
Priming Agents: A Novel Approach to Enhancing Cell-Free DNA Detection in Liquid Biopsies
2.
The Statistical Paradigm of Leukemia: From Evolving Epidemiology and Molecular Stratification to Precision Therapies and Future Horizons in Leukemia
3.
HPV Infection Review: Epidemiology, Risks, and Therapeutic Advances for Clinicians
4.
Mechanistic Depth and Clinical Impact of Rusfertide, Onyvide, IV Avastin, and Pemfexy
5.
Survival Rates in Cancer: Focus on Acute Myeloid Leukemia and Other Malignancies
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
An Eagles View - Evidence-based discussion on Iron Deficiency Anemia- Important Points to Know
2.
An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Conclusion
3.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part IV
4.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part V
5.
Current Scenario of Cancer- The Incidence of Cancer in Men
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation